Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06002425 · ClinicalTrials.gov registry record · NA
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
A NA study of Gastrointestinal Neoplasm Malignant, sponsored by Chinese Academy of Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 7
- Study locations
NCT06002425: Recruiting NA study of Gastrointestinal Neoplasm Malignant, sponsored by Chinese Academy of Sciences.
NCT06002425 is a NA study of Gastrointestinal Neoplasm Malignant that is actively recruiting participants, run by Chinese Academy of Sciences. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06002425, a NA study of Gastrointestinal Neoplasm Malignant, is actively recruiting participants, sponsored by Chinese Academy of Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
Conditions Studied
Interventions
- OTHER Clinician-Directed Treatment Plan
- OTHER ChatGPT-Assisted Treatment Plan
Study Locations (7)
Guangdong
- Jiangmen Central Hospital - Jiangmen
- The Fifth Affiliated Hospital of Sun Yat-sen University - Zhuhai
- Zhuhai People's Hospital - Zhuhai
California
- City of Hope - Duarte
Inner Mongolia
- Peking University Cancer Hospital (Inner Mongolia Campus) - Hohhot
Saxony-Anhalt
- University Hospital Magdeburg - Magdeburg
Other
- San Raffaele University Hospital, Italy - Milan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06002425
The ClinicalTrials.gov registry entry for NCT06002425 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The listed sponsor is Chinese Academy of Sciences, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastrointestinal Neoplasm Malignant appearing as the primary indexed condition, and to 2 interventions - of which Clinician-Directed Treatment Plan is the first listed.
NCT06002425 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Guangdong, California, Inner Mongolia.
Frequently Asked Questions
What is clinical trial NCT06002425 about?
NCT06002425 is a clinical study titled "Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models". This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
What is the current status of trial NCT06002425?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-08-29. Estimated completion is 2028-12-31.
What conditions does trial NCT06002425 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasm Malignant.
What interventions are being tested in trial NCT06002425?
The interventions under investigation include: Clinician-Directed Treatment Plan (OTHER), ChatGPT-Assisted Treatment Plan (OTHER).
Who is sponsoring clinical trial NCT06002425?
This trial is sponsored by Chinese Academy of Sciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06002425 being conducted?
This trial has 7 study locations across California, Guangdong, Inner Mongolia, Saxony-Anhalt. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasm Malignant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.